Catherine Skari

Predicting Factors of Survival Rates Among α-and β-Thalassemia Patients: A Retrospective 10-Year Data Analysis

Background: Thalassemia is a genetic hemoglobinopathy in which a defective globin chain can cause transfusion-dependent anemia and other complications. As genotype…

CAD | Enjaymo Not Cost-Effective at Current Price, According to US Study

This conclusion was drawn from a cost-effectiveness study utilizing data from the Phase 3 CARDINAL clinical trial, which backed the…

SPOTLIGHT | TIF Wins Prestigious HemaSphere Award at EHA2024

The HemaSphere Awards were presented by the official journal of the European Hematology Association (EHA)  during Europe’s most important scientific…

NEW PUBLICATION | Nutrition in Thalassaemia: A Guide for Patients, Families, and Caregivers

The guide encompasses: An overview of the nutritional needs specific to people with thalassaemia Methods for nutritional assessment Detailed explanations…

WORLD BLOOD DONOR DAY 2024 | 20 Years of Celebrating Giving: Thank You Blood Donors!

TIF STUDY | Patient and Caregiver Perceptions of Thalassaemia Care in 2023

The study revealed that most patients with thalassaemia are receiving adequate treatment, including regular blood transfusions, chelation therapy, proper monitoring,…

WHA77 SIDE EVENT | Access to Novel Therapies Globally: Opportunities and Challenges

The Side Event entitled “Access to Novel Therapies Globally: Opportunities and Challenges” is set to take place Friday, 31 May…

EDUCATION | TIF’s Concludes Regional Capacity Building Workshop in Romania

High Survival Rates for SCD Patients with Groundbreaking Transplant Approach

A bone marrow transplant strategy that avoids high-dose chemotherapy to prevent an immune reaction against donor stem cells has demonstrated…